Clinical Trial Update: Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dose-response efficacy and safety of Botulinum Toxin Type A for spasticity in limbs related to cerebral palsy; study completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Spasticity

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Cerebral Palsy, Spasticity | Phase 3 | Status: COMPLETED | Results posted: 2020-08-03